Streetbeat News

Analyst Ratings

QQQ

SPY

Allianz chief economic adviser Mohamed El-Erian believes the Federal Reserve has three primary options for interest rates, but none are optimal. He argues that recent data favors a rate hike and that the central bank should raise rates by 0.25 percentage points if it is genuinely data-dependent and committed to its 2% inflation target.

Portfolio Pulse from Bhavik Nair

June 13, 2023 | 4:27 am

DAVA

In the last 3 months, 11 analysts have provided 12-month price targets for Endava (NYSE:DAVA), with an average price target of $81.0, a decrease of 16.68% from the previous average of $97.22.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 9:02 pm

ELF

Over the past 3 months, 18 analysts have published their opinion on e.l.f. Beauty (NYSE:ELF) stock, with an average price target of $105.28, slightly below the current price of $105.44. The average price target has increased by 15.62% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 9:02 pm

AMH

Over the past 3 months, 11 analysts have published their opinion on American Homes 4 Rent (NYSE:AMH) stock, with an average 12-month price target of $35.91. The average price target has increased by 3.73% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 9:01 pm

ANF

In the last 3 months, 10 analysts have provided 12-month price targets for Abercrombie & Fitch (NYSE:ANF), with an average target of $31.1, up 13.09% from the previous average of $27.50. The ratings include 2 bullish, 3 somewhat bullish, 4 indifferent, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 9:01 pm

ARQT

In the last 3 months, 11 analysts have offered 12-month price targets for Arcutis Biotherapeutics (NASDAQ:ARQT), with an average price target of $41.55, down 15.2% from the previous average of $49.00.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 9:01 pm

KMX

In the last quarter, 8 analysts have rated CarMax (NYSE:KMX) with an average price target of $61.75, implying a downside compared to the current price of $79.53. The average price target has increased by 6.15% over the past month.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 9:00 pm

DV

In the last quarter, DoubleVerify Hldgs (NYSE:DV) received 5 bullish and 7 somewhat bullish analyst ratings. The company's average 12-month price target is $34.58, up 3.22% from the previous average of $33.50.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 8:02 pm

NCLH

Over the past 3 months, 8 analysts have published their opinions on Norwegian Cruise Line (NYSE:NCLH) stock, with an average 12-month price target of $16.12. The current average has decreased by 7.89% from the previous average price target of $17.50.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 8:02 pm

AXSM

In the last quarter, Axsome Therapeutics (NASDAQ:AXSM) received mostly bullish analyst ratings, with an average 12-month price target of $125.4, up 17.75% from the previous average of $106.50.

Portfolio Pulse from Benzinga Insights

June 12, 2023 | 8:02 pm